P-ISSN 2587-2400 | E-ISSN 2587-196X
EJMO. 2017; 1(3): 160-163 | DOI: 10.14744/ejmo.2017.65365

Gastric Cancer Patients with Bone Marrow Metastasis: A Single-Center Experience and Review of the Literature

Yakup Ergun1, Dogan Uncu1, Ozan Yazici1, Gokhan Ucar1, Ekin Konca Karabuga2, Nurullah Zengin1
1Department of Medical Oncology, Ankara Numune Training and Research Hospital, Ankara, Turkey, 2Department of Internal Medicine, Ankara Numune Training and Research Hospital, Ankara, Turkey

Objectives: The purpose of this study is to investigate bone marrow metastasis in patients with Gastric cancer. Methods: We retrospectively evaluated patients with gastric cancer who applied to our clinic between 2010-2016. Results: 896 patients with gastric cancer were included in the study. Patients had metastatic bone marrow in 8 patients. When the laboratory results were evaluated; in 5 patients trombocytopenia with anemia were present, 2 patients had only tromboscytopenia, one patient had only anemia. In all patients white blood cell count was within normal range. The median survival of the 8 patients in our study was 72 days. In our chemoteraphy group (6 patients) median survival was 77 days (range, 49 to 145 days), in the non-treatment group was 7,5 days (range, 3 to 12 days). Conclusion: Gastric cancer with bone marrow metastasis is usually seen in younger patients, and is related to poorly differantiated subtypes and is a disease with worse prognosis. Median survival with paliative chemotraphy is under 3 months.


Gastric Cancer Patients with Bone Marrow Metastasis: A Single-Center Experience and Review of the Literature. EJMO. 2017; 1(3): 160-163

Corresponding Author: Yakup Ergun

Full Text PDF